Norges Bank Evelo Biosciences, Inc. Transaction History

Norges Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.08 - $3.25 $23,539 - $956,286	-294,242 Closed	0 $0
Q2 2022 Aug 14, 2023	BUY	$1.46 - $3.55 $429,593 - $1.04 Million	294,242 New	294,242 $620,000
Q1 2022 May 12, 2023	BUY	$2.66 - $6.63 $782,683 - $1.95 Million	294,242 New	294,242 $997,000
Q1 2022 May 09, 2022	SELL	$2.66 - $6.63 $782,683 - $1.95 Million	-294,242 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$6.07 - $12.0 $1.79 Million - $3.53 Million	294,242 New	294,242 $1.79 Million
Q3 2021 Nov 14, 2022	BUY	$6.79 - $13.9 $2 Million - $4.09 Million	294,242 New	294,242 $2.07 Million
Q3 2021 Nov 05, 2021	SELL	$6.79 - $13.9 $2 Million - $4.09 Million	-294,242 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$9.43 - $16.6 $2.77 Million - $4.88 Million	294,242 New	294,242 $4.04 Million
Q2 2021 Aug 10, 2021	SELL	$9.43 - $16.6 $2.77 Million - $4.88 Million	-294,242 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$9.71 - $18.6 $2.86 Million - $5.47 Million	294,242 New	294,242 $3.15 Million

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.